Pharma News

Lysogene has ended its licensing deal with Sarepta Therapeutics for its LYS-SAF302, an experimental therapy for treating a rare inherited disease of the central nervous system called mucopolysaccha...

The European Medicines Agency’s (EMA) product safety committee has begun reviewing drugs treating an advanced liver disease that contain the active compound terlipressin. ...

The FDA has placed a clinical hold on Denali Therapeutics’ and Takeda Pharmaceutical’s experimental Alzheimer’s drug DNL919.

SHANGHAI, Jan. 17, 2022 /PRNewswire/ -- On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigati...

DEMENTIA takes away a person's memories and personality, which can be devastating for loved ones to watch. 

New Delhi: India’s Gennova Biopharmaceuticals is working on an omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told...

Indian generic drugmaker Marksans Pharma has won FDA approval for its cetirizine hydrochloride tablets.

A research effort led by Stanford scientists set the first Guinness World Record for the fastest DNA sequencing technique, which was used to sequence a human genome in just 5 hours and 2 minutes. ...

The virus that causes herpes is likely the main cause of multiple sclerosis (MS), a groundbreaking study has suggested.

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have t...

Tempol is being analysed in a double-blind, randomised, adaptive, Phase II/II clinical trial for Covid-19 treatment.

The FDA approved many new drugs and technologies over the past year, and in the dermatology world those approvals included treatments for a multitude of conditions. ...